• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

‘Both sides are wrong’: Longtime Obamacare critic says GOP is mistaken in shutdown struggle

by October 27, 2025
written by October 27, 2025

In the view of Avik Roy — one of the first and most vocal critics of the Affordable Care Act (ACA), also known as Obamacare — Republicans and Democrats alike have missed the mark in the healthcare debate that has dragged the government into a 24-day shutdown.

‘Both sides are wrong,’ Avik said. ‘I’m sympathetic to the Republican view, but it’s a strategic mistake.’

The way Roy sees things, Republican wariness over renewing expanded government subsidies should be directed at the bigger problem behind them.

‘The subsidies aren’t inherently the problem,’ Roy said. ‘If you want low-income people who are near the poverty line to have insurance, you’re going to have to subsidize. Subsidies have been a part of Republican [healthcare] plans and Democratic plans. I would argue that the approach to subsidies that Obamacare used was actually pretty reasonable.’ 

That doesn’t mean he believes the government’s current healthcare trajectory is sustainable, either.

The federal government entered a 24-day shutdown at the beginning of October when lawmakers failed to come to an agreement over spending legislation to begin the new fiscal year. Republicans advanced a short-term spending bill that would have bought more time for lawmakers to finalize funding for 2026. But Democrats, led by Senate Minority Leader Chuck Schumer, D-N.Y., and House Minority Leader Hakeem Jeffries, D-N.Y., have shot down that measure repeatedly, demanding that Congress first address expiring COVID-era insurance subsidies. 

As a part of its American Rescue Plan, the Biden administration greatly widened the pool of eligible applicants who could receive a federal subsidy to help pay for their Obamacare health insurance.

In its original form, Obamacare capped subsidies for anyone making over 400% of the federal poverty level. But that changed in 2021 when, as an emergency response to COVID-19, Congress temporarily removed that cap.

The cap will go back into effect at the end of 2025.

Findings by KFF, a healthcare policy think tank, indicate that over 90% of the 24 million Obamacare enrollees make use of the expanded credits. Letting them expire could leave those Obamacare enrollees suddenly footing a substantially heftier bill. But, according to the Committee of a Responsible Federal Budget, a nonpartisan fiscal policy think tank, continuing the policy would also come with a steep price tag; upwards of $30 billion annually.

Republicans — especially the Hill’s most fiscally conservative lawmakers — have called for the subsidies to expire to help reel the country’s spending back under control.

Despite agreeing with Republicans that Obamacare did little to make health insurance more affordable, Roy believes Republican insistence on letting them expire won’t solve Obamacare’s underlying problems that are driving prices higher: regulations. 

Roy believes Republicans should use the moment to negotiate, extending the subsidies for maybe one to two years for existing enrollees in exchange for a permanent fix of the costliest Obamacare regulations driving costs upward. 

‘In Switzerland [health insurance] costs $200 a month or $300 a month. The same plan in America costs $1,000 a month or $15,000 a month. Subsidizing it also costs a lot. But having a scale where the subsidy fades out gradually as you go up the income scale — that part is fine.’

Roy praised efforts from the Trump administration to bring the underlying costs of healthcare down, most recently through the most favored nation strategy. Under that plan, the Trump administration had leveraged the price other countries pay for pharmaceuticals to bring U.S. prices down.

In theory, the most favored nation plan would set American prices at the lowest rates other countries pay.

‘They’re not actually deals that truly establish most favored nation status because it’s company by company, and they are on particular drugs. But the general idea — if you want to participate in the U.S. market you’ve got to give us the lowest price you give any other advanced economy — I think that’s eminently reasonable,’ Roy said of the administration’s negotiations. 

In response to Democratic demands, Republicans in Congress maintain that the enhanced premium tax credits are completely unrelated to the government’s funding and rejected those demands out of hand.

The Senate has voted on a short-term funding bill 12 times since the beginning of the shutdown and appeared no closer to finding a resolution when the lawmakers left town on Thursday.

The Senate will return to Washington, D.C., at the beginning of next week. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Inside the Mamdani Machine: Soros cash, socialists and radical imams engineered Zohran Mamdani’s path to power
next post
The Tomahawk factor: US long-range missiles are the battlefield gamechanger Putin should fear

related articles

FBI surges resources to Minnesota as Director Patel...

December 28, 2025

DAVID MARCUS: What the conservative think tank wars...

December 28, 2025

Africa’s Christian Crisis: How 2025’s deadly attacks finally...

December 28, 2025

Iranian president says his country is at ‘total...

December 28, 2025

2025 shockers: The biggest moments that rocked the...

December 27, 2025

Most shocking examples of Chinese espionage uncovered by...

December 27, 2025

Zelenskyy says Ukraine, ahead of Trump meeting, is...

December 27, 2025

Zelenskyy says fresh Russian attack on Ukraine shows...

December 27, 2025

Trump’s peace through strength in 2025: where wars...

December 27, 2025

DAVID MARCUS: Ben Sasse is dying, but his...

December 27, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Federal judge dumps Peter Strzok lawsuit over FBI firing for anti-Trump texts

    September 24, 2025
  • Former Iraqi refugee living in Texas pleads guilty to conspiring to support ISIS

    March 10, 2025
  • Trump to meet with Netanyahu as he pushes for ceasefire between Israel, Gaza

    July 1, 2025
  • Fortnite applies to launch on Apple’s App Store after Epic Games court win

    May 11, 2025
  • Founder of Catholic ministry Word on Fire to attend Trump address to Congress

    March 3, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,224)
  • Investing (740)
  • Stock (964)

Latest Posts

  • RFK Jr says this is ‘2-man race’ after Biden drops presidential bid

    July 22, 2024
  • Ethereum, after a month, again above the $2700 level

    September 24, 2024
  • Trump picks Dr. Marty Makary as Food and Drug Administration commissioner

    November 23, 2024

Recent Posts

  • Citi upgrades Coinbase stock to Buy with $345 target: Is a 30% gain within reach?

    July 23, 2024
  • Backlash against Sydney Sweeney ‘jeans/genes’ ad gets mocked by WH: Americans are ‘tired of this bulls—’

    July 30, 2025
  • Comcast announces plan to spin off cable channels, including MSNBC, CNBC and USA

    November 20, 2024

Editor’s Pick

  • Biden-Harris appeasement didn’t delay Iran retaliation against Israel. Here’s what really happened

    August 12, 2024
  • US champions Lebanon’s response to Hezbollah disarmament, hints at Abraham Accords opportunity

    July 7, 2025
  • Lockheed Martin’s stock soars: What’s behind the 7-day rally?

    August 1, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock